N-(4-Chlorophenyl)piperazine dihydrochloride
Properties
- Molecular formula
- C10H15Cl3N2
- Molar mass
- 269.59 g/mol
- Exact mass
- 268.0301 Da
- logP
- 2.59Crippen estimate
- Polar surface area
- 15.3 Ų
- H-bond donors / acceptors
- 1 / 2
- Rotatable bonds
- 1
Hazards
Warning
- H315 Causes skin irritation100% of notifiers
- H319 Causes serious eye irritation100% of notifiers
- H335 May cause respiratory irritation100% of notifiers
Aggregated from 43 ECHA notifications, via PubChem; a share says how many notifiers assign that statement.
Precautionary statements
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, P501
Identifiers
CAS number
38869-46-4SMILES
Cl.Cl.Clc1ccc(N2CCNCC2)cc1InChIKey
ORKOLISAYPZGHP-UHFFFAOYSA-NInChI
InChI=1S/C10H13ClN2.2ClH/c11-9-1-3-10(4-2-9)13-7-5-12-6-8-13;;/h1-4,12H,5-8H2;2*1HWeigh it out
Type any one amount. The others follow from the molar mass.
Names and synonyms
4 names
- Piperazine, 1-(4-chlorophenyl)-, hydrochloride (1:2)
- Piperazine, 1-(4-chlorophenyl)-, dihydrochloride
- 1-(4-Chlorophenyl)piperazine dihydrochloride
- 4-(4-Chlorophenyl)piperazine dihydrochloride
Work with N-(4-Chlorophenyl)piperazine dihydrochloride
Stereoisomers, salts and isotopologues
The same compound in another form: other stereochemistry, a salt or hydrate, the free acid or base, or an isotope-labelled version.
Similar compounds
1-(3-Chlorophenyl)piperazine hydrochloride13078-15-466 % similar
1-(3-Chlorophenyl)piperazine monohydrochloride65369-76-866 % similar
1-Phenylpiperazine hydrochloride2210-93-766 % similar
1-(4-Fluorophenyl)piperazine dihydrochloride64090-19-365 % similar
1-(4-Bromophenyl)piperazine monohydrochloride68104-62-165 % similar
Piperazine, 1-(3,4-dichlorophenyl)-, hydrochloride (1:2)76835-17-161 % similar
N-(4-Methoxyphenyl)piperazine dihydrochloride38869-47-559 % similar
1-(4-Methoxyphenyl)piperazine hydrochloride84145-43-759 % similar
Tanimoto similarity of circular fingerprints over the whole catalogue.